- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 1st, 2005
Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anticancer toxins, all while leaving healthy cells unscathed. Investigators at the Massachusetts Institute of Technology have designed a multifunctional nanoparticle to do just that. The dual-chamber, double-acting, drug-packing "nanocell" proved effective and safe, with prolonged survival, against two distinct forms of cancers-melanoma and Lewis lung cancer-in mice. This work, conducted by a multidisciplinary team led by Ram Sasisekharan, Ph.D., of MIT, was published in the journal Nature.
The nanocell worked better against melanoma than lung cancer, indicating the need to tweak the design for different cancers. "This model enables us to rationally and systematically evaluate drug combinations and loading mechanisms," says Dr. Sasisekharan. "It's not going to stop here. We want to build on this concept."
|Related News Press|
Molecular trick alters rules of attraction for non-magnetic metals August 5th, 2015
Global Carbon Nanotubes Industry 2015: Acute Market Reports August 4th, 2015
Glitter from silver lights up Alzheimer's dark secrets August 25th, 2015
Cervical cancer detection goes portable August 25th, 2015
Antibacterial Nanocomposite Prevents Transmission of Infectious Diseases August 24th, 2015
Successful boron-doping of graphene nanoribbon August 27th, 2015
Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015